[HTML][HTML] Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1/STAT6-microRNA-23a feedback loop in macrophage M2 …
Y Zheng, S Ji, X Li, L Wen - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Hepatic fibrosis is the critical pathological stage in the progression of chronic liver disease to
cirrhosis and hepatocellular carcinoma (HCC). However, no approved anti-hepatic fibrosis …
cirrhosis and hepatocellular carcinoma (HCC). However, no approved anti-hepatic fibrosis …
Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1/STAT6-microRNA-23a feedback loop in macrophage M2 polarization
Y Zheng, S Ji, X Li, L Wen - Biomedicine & pharmacotherapy … - pubmed.ncbi.nlm.nih.gov
Hepatic fibrosis is the critical pathological stage in the progression of chronic liver disease to
cirrhosis and hepatocellular carcinoma (HCC). However, no approved anti-hepatic fibrosis …
cirrhosis and hepatocellular carcinoma (HCC). However, no approved anti-hepatic fibrosis …
Qijia rougan formula ameliorates ECM deposition in hepatic fibrosis by regulating the JAK1/STAT6-microRNA-23a feedback loop in macrophage M2 polarization.
Y Zheng, S Ji, X Li, L Wen - Biomedicine & Pharmacotherapy …, 2023 - europepmc.org
Hepatic fibrosis is the critical pathological stage in the progression of chronic liver disease to
cirrhosis and hepatocellular carcinoma (HCC). However, no approved anti-hepatic fibrosis …
cirrhosis and hepatocellular carcinoma (HCC). However, no approved anti-hepatic fibrosis …